Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-04-27 @ 7:01 AM
Study NCT ID:
NCT05141357
Status:
TERMINATED
Last Update Posted:
2025-12-24
First Post:
2021-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer
Sponsor:
HUYABIO International, LLC.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HBI-8000-305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None